Evoke Pharma Completes Manufacturing of Commercial Scale Registration Batches of Gimoti™ Read more about Evoke Pharma Completes Manufacturing of Commercial Scale Registration Batches of Gimoti™
Evoke Pharma to Resubmit Gimoti™ NDA Based on FDA Meeting Minutes and Announces Second Quarter 2019 Financial Results Read more about Evoke Pharma to Resubmit Gimoti™ NDA Based on FDA Meeting Minutes and Announces Second Quarter 2019 Financial Results
Evoke Pharma Requests Type A FDA Meeting to Plan for Resubmission of Gimoti™ NDA Read more about Evoke Pharma Requests Type A FDA Meeting to Plan for Resubmission of Gimoti™ NDA
Evoke Pharma Reports First Quarter 2019 Financial Results Read more about Evoke Pharma Reports First Quarter 2019 Financial Results
Evoke Pharma Receives Complete Response Letter and Recommendations to Address Deficiencies from FDA for Gimoti™ NDA Read more about Evoke Pharma Receives Complete Response Letter and Recommendations to Address Deficiencies from FDA for Gimoti™ NDA
Evoke Pharma Submits Response to FDA Review Letter for Gimoti™ NDA Read more about Evoke Pharma Submits Response to FDA Review Letter for Gimoti™ NDA
Evoke Pharma Reports Fourth Quarter and Full Year 2018 Financial Results and FDA Communication Read more about Evoke Pharma Reports Fourth Quarter and Full Year 2018 Financial Results and FDA Communication
Evoke Pharma Receives Preliminary FDA Communication on Gimoti™ NDA Read more about Evoke Pharma Receives Preliminary FDA Communication on Gimoti™ NDA
Evoke Pharma Schedules Conference Call and Webcast for Fourth Quarter and Full-Year 2018 Financial Results Read more about Evoke Pharma Schedules Conference Call and Webcast for Fourth Quarter and Full-Year 2018 Financial Results
Evoke Pharma Signs Commercial and Financial Agreement for its Lead Product Gimoti™ in the U.S. with Novos Growth Partners Read more about Evoke Pharma Signs Commercial and Financial Agreement for its Lead Product Gimoti™ in the U.S. with Novos Growth Partners